Glaukos (GKOS) Short Interest Ratio & Short Volume → Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad) Free GKOS Stock Alerts $100.11 -0.82 (-0.81%) (As of 04/25/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Glaukos Short Interest DataCurrent Short Volume3,290,000 sharesPrevious Short Volume3,490,000 sharesChange Vs. Previous Month-5.73%Dollar Volume Sold Short$318.49 millionShort Interest Ratio / Days to Cover4.9Last Record DateApril 15, 2024Outstanding Shares50,190,000 sharesPercentage of Shares Shorted6.56%Today's Trading Volume286,328 sharesAverage Trading Volume660,230 sharesToday's Volume Vs. Average43% Short Selling Glaukos ? Sign up to receive the latest short interest report for Glaukos and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatGKOS Short Interest Over TimeGKOS Days to Cover Over TimeGKOS Percentage of Float Shorted Over Time Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> Glaukos Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20243,290,000 shares $318.49 million -5.7%N/A4.9 $96.81 3/31/20243,490,000 shares $329.07 million -4.6%N/A4.9 $94.29 3/15/20243,660,000 shares $312.89 million -0.8%N/A5.1 $85.49 2/29/20243,690,000 shares $326.97 million +1.7%N/A4.5 $88.61 2/15/20243,630,000 shares $348.95 million -8.6%N/A4.4 $96.13 1/31/20243,970,000 shares $353.37 million -47.4%N/A4.8 $89.01 Get the Latest News and Ratings for GKOS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Glaukos and its competitors with MarketBeat's FREE daily newsletter. 1/15/20247,550,000 shares $668.10 million +3.4%19.5%9.1 $88.49 12/31/20237,300,000 shares $580.28 million +3.0%N/A10.7 $79.49 12/15/20237,090,000 shares $577.41 million +2.2%N/A10.5 $81.44 11/30/20236,940,000 shares $443.54 million +3.7%N/A13 $63.91 11/15/20236,690,000 shares $439.53 million +7.4%N/A13.6 $65.70 10/31/20236,230,000 shares $424.89 million +1.8%N/A13 $68.20 10/15/20236,120,000 shares $401.41 million -8.0%N/A13.9 $65.59 9/30/20236,650,000 shares $500.41 million +0.8%N/A14.3 $75.25 9/15/20236,600,000 shares $495.83 million +1.9%N/A15.1 $75.13 8/31/20236,480,000 shares $486.91 million +9.6%N/A14 $75.14 8/15/20235,910,000 shares $443.43 million +2.1%N/A11.6 $75.03 7/31/20235,790,000 shares $446.58 million -1.0%N/A10.9 $77.13 7/15/20235,850,000 shares $462.68 million -1.4%12.7%11.7 $79.09 6/30/20235,930,000 shares $422.28 million +2.2%12.9%13.4 $71.21 6/15/20235,800,000 shares $391.44 million +4.3%12.6%13.1 $67.49 5/31/20235,560,000 shares $316.92 million +1.5%12.1%12.9 $57.00 5/15/20235,480,000 shares $328.31 million +7.7%11.9%13.4 $59.91 4/30/20235,090,000 shares $241.83 million +1.0%11.0%12.6 $47.51 4/15/20235,040,000 shares $245.25 million -1.0%11.0%13.1 $48.66 3/31/20235,090,000 shares $255.01 million +5.0%11.1%12.6 $50.10 3/15/20234,850,000 shares $233.62 million +2.8%10.6%12 $48.17 2/28/20234,720,000 shares $222.93 million +5.6%10.3%11.8 $47.23 2/15/20234,470,000 shares $233.51 million +0.5%9.8%11.7 $52.24 1/31/20234,450,000 shares $218.27 million -0.5%9.8%11.8 $49.05 1/15/20234,470,000 shares $219.97 million +2.3%9.8%11.7 $49.21 12/30/20224,370,000 shares $190.88 million +5.3%9.6%11.3 $43.68 12/15/20224,150,000 shares $179.78 million +0.7%9.1%10.8 $43.32 11/30/20224,120,000 shares $191.87 million +0.5%9.0%9.4 $46.57 11/15/20224,100,000 shares $207.87 million -1.7%9.0%8.1 $50.70 10/31/20224,170,000 shares $233.81 million +0.2%9.1%7.9 $56.07 10/15/20224,160,000 shares $223.72 million +5.3%9.1%7.7 $53.78 9/30/20223,950,000 shares $210.30 million +4.0%8.7%7 $53.24 9/15/20223,800,000 shares $215.99 million +49.0%8.4%6.7 $56.84 8/31/20222,550,000 shares $123.80 million +58.4%5.6%4.7 $48.55Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> GKOS Short Interest - Frequently Asked Questions What is Glaukos' current short interest? Short interest is the volume of Glaukos shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 3,290,000 shares of GKOS short. Learn More on Glaukos' current short interest. What is a good short interest ratio for Glaukos? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GKOS shares currently have a short interest ratio of 5.0. Learn More on Glaukos's short interest ratio. Which institutional investors are shorting Glaukos? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Glaukos: PEAK6 Investments LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Glaukos' short interest increasing or decreasing? Glaukos saw a drop in short interest in the month of April. As of April 15th, there was short interest totaling 3,290,000 shares, a drop of 5.7% from the previous total of 3,490,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Glaukos' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Glaukos: Halozyme Therapeutics, Inc. (6.55%), Bausch + Lomb Co. (4.26%), Option Care Health, Inc. (2.51%), CRISPR Therapeutics AG (17.37%), Organon & Co. (4.29%), Krystal Biotech, Inc. (8.59%), Blueprint Medicines Co. (6.94%), BridgeBio Pharma, Inc. (10.86%), Lantheus Holdings, Inc. (6.95%), Madrigal Pharmaceuticals, Inc. (17.14%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Glaukos stock? Short selling GKOS is an investing strategy that aims to generate trading profit from Glaukos as its price is falling. GKOS shares are trading down $0.82 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Glaukos? A short squeeze for Glaukos occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GKOS, which in turn drives the price of the stock up even further. How often is Glaukos' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GKOS, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Halozyme Therapeutics Short Interest Bausch + Lomb Short Interest Option Care Health Short Interest CRISPR Therapeutics Short Interest Organon & Co. Short Interest Krystal Biotech Short Interest Blueprint Medicines Short Interest BridgeBio Pharma Short Interest Lantheus Short Interest Madrigal Pharmaceuticals Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:GKOS) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarnings